Patient Care

This page includes news coverage of various aspects of patient healthcare, including new technology innovations, what is working, what is not, personalized medicine and remote and telemedicine delivery. Find specific news in the areas of Care DeliveryDigital TransformationPrecision MedicineRemote Monitoring and Telehealth.

Thumbnail

ACR Council passes resolution advocating for the protection of radiologists in states that ban abortion

“I am delighted by the overwhelming support Resolution #11 received at the ACR meeting," one of its supporters told Radiology Business

Radiology provider Akumin highlights ‘robust’ growth in PET/CT volumes with no signs of slowing

The Plantation, Florida, company saw volumes from the modality leap 16.1% on a same-store basis when compared to Q1 of 2022, leaders said. 

IBM WatsonX

Industry Watcher’s Digest

Buzzworthy developments of the past several days.

artificial intelligence warning united nations

Int’l panel: Safeguard human health against AI now—or risk losing the chance forever

As the world grapples with the potential downsides of generative AI, a global group of healthcare researchers is warning of health perils that could emanate from well beyond clinical settings.

Thumbnail

Nearly 90% of significant incidental findings on lung cancer screenings are considered reportable

These findings highlight a need for more stringent and standardized reporting guidelines relative to incidental findings, authors of the new study suggested.

Thumbnail

1 in 3 cardiologists have been sued, though they often win when it happens

Overall, 31.2% of U.S. physicians say they have been sued. When looking at only cardiologists, the percentage is slightly higher.

The new MRI contrast agent gadopiclenol, sold under the trade names Elucirem and Vueway by Bracco and Guerbet, used 50% less gadolinium that current MRI agents. #RSNA22 #RSNA

New contrast agent earns positive safety classification from ACR

The ACR Committee on Drugs and Contrast Media stated that exposure to the gadolinium-based contrast agent represents a “sufficiently low or possibly nonexistent” risk to patients.

heart health attack cardiology

Industry Watcher’s Digest

Buzzworthy developments of the past few days.